drugset / Trial / NCT02897349
Linagliptin Add-on to Insulin Background Therapy
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy and safety of linagliptin compared to placebo when added on to insulin therapy alone or in combination with metformin in Chinese patients with type 2 diabetes mellitus with insufficient glycaemic control
Timeline
- Start
- 2016-09-30
- Primary completion
- 2019-01-11
- Completion
- 2019-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Small molecule | — | Oral |
| Background | Insulin | Protein / enzyme biologic | — | — |
| Background | Metformin | Small molecule | — | — |